ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,342.36
2.32%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Bone Biologics Corporation (BBLG)

  7. Bone Biologics Corporation (BBLG) Noticias

BBLG Bone Biologics Corporation

1.723
-0.1243 (-6.73%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bone Biologics Corporation BBLG NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.1243 -6.73% 1.723 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.90 1.80 1.9418 1.85 1.8473
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/3/202415:15BWBone Biologics Announces Closing of $2.0 Million Public..
04/3/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
04/3/202416:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
04/3/202408:15BWBone Biologics Announces Pricing of $2.0 Million Public..
01/3/202407:05EDGAR2Form 8-K - Current report
01/3/202407:00BWBone Biologics Reports Progress With NB1 Clinical Program
26/2/202415:50EDGAR2Form S-1/A - General form for registration of securities..
23/2/202416:09EDGAR2Form S-1/A - General form for registration of securities..
21/2/202416:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/2/202417:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202409:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202419:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202416:09EDGAR2Form S-1 - General form for registration of securities under..
19/1/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202416:21EDGAR2Form S-3/A - Registration statement under Securities Act of..
12/1/202416:15EDGAR2Form 8-K - Current report
11/1/202407:15EDGAR2Form 8-K - Current report
11/1/202407:00BWBone Biologics Appoints Healthcare Finance Veteran Robert E...
10/1/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202407:15EDGAR2Form 8-K - Current report
10/1/202407:00BWBone Biologics Regains Compliance with Nasdaq Continued..
05/1/202416:15EDGAR2Form S-3 - Registration statement under Securities Act of..
02/1/202416:15EDGAR2Form 8-K - Current report
02/1/202414:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/12/202316:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/12/202307:05EDGAR2Form 8-K - Current report
18/12/202307:00BWBone Biologics Announces 1-for-8 Reverse Stock Split
13/12/202308:15EDGAR2Form 8-K - Current report
27/11/202305:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/11/202311:38BWBone Biologics Announces Closing of Registered Direct..
20/11/202306:46EDGAR2Form 8-K - Current report
20/11/202306:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/11/202306:00EDGAR2Form DEF 14A - Other definitive proxy statements
20/11/202305:50EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
16/11/202315:43BWBone Biologics Announces Registered Direct Offering Priced..
14/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:51EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202305:06EDGAR2Form 8-K - Current report
29/9/202316:19EDGAR2Form 8-K - Current report
26/9/202307:00BWBone Biologics Provides Scientific Update on NB1 Bone Graft..
20/9/202313:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202313:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202313:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202315:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/9/202310:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202315:01EDGAR2Form 8-K - Current report
12/9/202310:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202309:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
BBLG
Bone Biologics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados